Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

526
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
526
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

825
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
825
Ethical Dilemmas II01:30

Ethical Dilemmas II

2.3K
Resolving an ethical dilemma in healthcare involves a systematic approach that considers every aspect of the issue, respecting both the patient's needs and values and the healthcare professional's ethical obligations. Here are potential steps to resolve an ethical dilemma:
2.3K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Data Validation01:03

Data Validation

6.3K
Data validation is an essential part of a comprehensive assessment. Validation is confirming or verifying and opening the door to gathering more assessment data as it clarifies vague or unclear data. The process of checking and verifying the collected information is called data validation. The primary purpose of data validation is to ensure data is as free from error, bias, and misinterpretation as possible.
Nursing assessment guides are generally based on holistic models rather than medical...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Performance of Alzheimer Disease Plasma Biomarkers in Patients With Prion Diseases.

Neurology·2026
Same author

Attitudes Towards Brain Health and Dementia Risk Reduction Among Minoritised Ethnic Communities in the United Kingdom: A Cross-Sectional Survey Analysis.

International journal of geriatric psychiatry·2026
Same author

Recruitment strategies in a diverse Parkinson's disease cohort: lessons from the East London Parkinson's Disease Project.

BMJ neurology open·2026
Same author

UK consensus on pregnancy in multiple sclerosis: An update to 'Association of British Neurologists' guidance.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Sternum-worn vibrotactile device in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot trial.

NPJ Parkinson's disease·2026
Same author

The Coronavirus Disease 2019 Impact on Plastic Surgery Training: A 9-year National Analysis of Case Log Disruptions and Recovery.

Plastic and reconstructive surgery. Global open·2026

Related Experiment Video

Updated: Jan 18, 2026

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
06:16

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Published on: June 6, 2020

4.2K

The Nottingham consensus on dementia risk reduction policy: recommendations from a modified Delphi process.

Harriet Demnitz-King1, Sube Banerjee2, Claudia Cooper3

  • 1Centre for Psychiatry and Mental Health, Wolfson Institute of Population Health, Queen Mary University, London, UK. h.demnitz-king@qmul.ac.uk.

Nature Reviews. Neurology
|January 16, 2026
PubMed
Summary

Developing effective dementia risk reduction strategies requires addressing health inequalities. This study outlines 56 actionable policy recommendations for dementia prevention, focusing on public health, individual and population interventions, and research.

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.9K
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

33.8K

Related Experiment Videos

Last Updated: Jan 18, 2026

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
06:16

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Published on: June 6, 2020

4.2K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.9K
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

33.8K

Area of Science:

  • Public Health
  • Neuroscience
  • Health Policy

Background:

  • Translating dementia risk reduction evidence into equitable public health policy is challenging.
  • The National Institute for Health and Care Research Policy Research Unit in Dementia and Neurodegeneration (DeNPRU-QM) addressed this gap.

Purpose of the Study:

  • To develop actionable policy recommendations for dementia risk reduction in England.
  • To provide guidance for dementia prevention strategies in other countries.

Main Methods:

  • Convened a multidisciplinary panel of 40 experts.
  • Conducted a 2-day workshop and a three-round modified Delphi survey.
  • Evaluated and refined statements on dementia prevention and risk reduction.

Main Results:

  • Achieved consensus on 56 recommendations across four domains: public health messaging, individual interventions, population interventions, and research commissioning.
  • Emphasized addressing health inequalities to prevent exacerbating disparities.
  • Highlighted the need for clear communication, targeted interventions, and sustained research investment.

Conclusions:

  • The recommendations offer a foundation for evidence-based dementia prevention strategies.
  • Prioritizing equity and addressing structural inequities is crucial for dementia risk reduction.
  • Cross-sector advocacy is vital for policy adoption and implementation.